Clinical Trials Browser

Phase 1 × Camurati-Engelmann Syndrome × Gemcitabine × Clear all

NCT02937272 2025-10-20

A Study of LY3200882 in Participants With Solid Tumors

Phase 1 Active not recruiting

Camurati-Engelmann Syndrome